SREBP-dependent lipidomic reprogramming as a broad-spectrum antiviral target

Shuofeng Yuan(University of Hong Kong - Shenzhen Hospital), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Dong Yang(Yancheng Central Blood Station), Kelvin Kai‐Wang To(Hong Kong Science and Technology Parks Corporation), Man Chun Chiu(Unknown), Dong‐Yan Jin(University of Hong Kong), Lei Wen(Queen Mary Hospital), Hin Chu(University of Hong Kong), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Kong‐Hung Sze(University of Hong Kong), Stanley Perlman(University of Iowa), Cyril Chik‐Yan Yip(Queen Mary Hospital), Pok-Man Lai(University of Hong Kong), Zi‐Wei Ye(Harbin University of Science and Technology), Xiaoyu Zhao(Queen Mary Hospital), Dongdong Chen(University of Hong Kong), Cun Li(Xinjiang Medical University), Jingjing Huang(University of Hong Kong), Chris Chan(University of Hong Kong), Bingpeng Yan(Hong Kong Science and Technology Parks Corporation), Ivy Hau-Yee Chan(Queen Mary Hospital), Kin‐Hang Kok(University of Hong Kong), Johnson Yiu‐Nam Lau(Hong Kong Baptist University), Richard Yi-Tsun Kao(University of Hong Kong), Jie Zhou(Chinese University of Hong Kong), Kah-Meng Tee(University of Hong Kong), Vincent Kwok‐Man Poon(Queen Mary Hospital)
Nature Communications
January 4, 2019
Cited by 259


Related Papers